Not Yet Recruiting
Neoadjuvant Chemoradiotherapy Followed by Chemotherapy With or Without Tislelizumab for Resectable Ultra-low Rectal Cancer: The RELIEVE-02 Study
NCT07132463
- Conditions
- Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +9 more
- Locations
-
Not specified